ESR1 and cancer: Furthermore, several RBPs have also been demonstrated to mediate the response of cancer cells to anti-cancer drugs, such as estrogen receptor α (ERα)14 and eukaryotic translation initiation factor 2 subunit beta (EIF2S2)15.